0570.HK
Bayzed does healthcare

China Traditional Chinese Medicine Holdings Co. Ltd. (0570.HK) on Wednesday warned that it expects to report its profit for all of 2024 fell by 90% to 100%, while its adjusted profit also fell by 50% to 60% year-on-year.

The company’s profit totaled 1.4 billion yuan ($191 million) in 2023, according to its latest annual report, meaning last year’s profit will fall to 140 million yuan or even to nil.

The company blamed the big drop on price cuts required by China’s centralized procurement system, as well as intensifying market competition and relatively high costs of medicinal materials. It added that credit, goodwill and plant impairment costs increased during the period. Its profit was also affected by remedial taxes on some of its subsidiaries last year.

Shares of China Traditional Chinese Medicine fell 6.3% to HK$1.92 in Thursday trading after the profit warning’s release.

By Lau Chi HangTo subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Illustration of Hong Kong as a ipo pipeline and crypto lab for China

Hong Kong: China’s IPO pipeline and crypto lab

Companies raised $13.6 billion through Hong Kong IPOs in the first half of the year, giving the city the global fundraising title for that period. What's behind the sudden boom? And a growing number of Chinese companies are experimenting with cryptocurrencies in Hong Kong, even as such currencies are banned on the Mainland. What's driving such different approaches on the Mainland and in Hong Kong?